Viewing Study NCT05742503


Ignite Creation Date: 2025-12-24 @ 7:44 PM
Ignite Modification Date: 2025-12-25 @ 5:22 PM
Study NCT ID: NCT05742503
Status: COMPLETED
Last Update Posted: 2023-02-24
First Post: 2022-12-15
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Progesterone Containing Contraceptive Methods on Endogenous Progesterone Level
Sponsor: Tanta University
Organization:

Study Overview

Official Title: Effects of Different Progesterone Containing Contraceptive Methods on Safety and Endogenous Progesterone Level
Status: COMPLETED
Status Verified Date: 2023-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The aim of this study is to assess the effect of different progesterone containing contraceptive methods on safety and endogenous progesterone level
Detailed Description: Progestogen-only' contraceptives are presented as injections, implants, oral formulations, hormone-releasing intrauterine methods and emergency contraceptives. These substances could be used by females who are breastfeeding or have other contraindications to estrogen treatment, including those who are immediately postpartum, have thalassemia, sickle-cell disease, gallbladder disease, or currently experiencing thrombo-embolic disorders, valvular heart disease, ischemic heart disease.

Intrauterine, injectable methods and contraceptive implants named as long-acting reversible contraceptives (LARC) are the more efficient reversible contraceptive approaches are highly effective, longer-acting contraceptive methods levels.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: